Trial Profile
Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2023
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Arterial occlusive disorders; Chronic limb-threatening ischemia; Intermittent claudication
- Focus Adverse reactions
- Acronyms DCB-SFA
- 14 Mar 2023 Planned End Date changed from 1 Jun 2021 to 1 Dec 2027.
- 14 Mar 2023 Status changed from recruiting to active, no longer recruiting.
- 24 Nov 2016 Status changed from not yet recruiting to recruiting.